BPA for tymlos

Active Awarded Last action

Contract number
36E79723A0008
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 96% complete
IDV ceiling
$18,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Radius Health, Inc. (UEI: XWM2P8FKM1Y5) was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs National Acquisition Center on December 20, 2022, for the supply of Tymlos (abaloparatide), a pharmaceutical product used to treat osteoporosis. The contract carries a ceiling value of $18.5 million and extends through December 19, 2026, with no set-aside provisions applied. The BPA was established under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), leveraging Radius Health's specialized capability as the sole manufacturer and supplier of this injectable medication to the federal government. The award enables the Veterans Health Administration to efficiently procure Tymlos through delivery orders to meet osteoporosis treatment requirements across VA Medical Centers and VA Health Administration offices nationwide.

The contract structure accommodates pricing updates through fiscal year 2026, allowing the VA to issue firm fixed-price delivery orders for Tymlos supplies as clinical demand dictates. Radius Health serves as the prime contractor with no subcontractors identified, maintaining direct responsibility for pharmaceutical product delivery to VA facilities. This BPA consolidates the VA's procurement of abaloparatide injections under a single vehicle, streamlining the ordering process while securing supply continuity for this specialized bone-health medication across the VA healthcare system during the performance period.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · 2026 public law pricing updates. $0
Exercise an Option P00006 · This modification is issued to exercise option year 3 on BPA 36E79723A0008. $0
Supplemental Agreement for work within scope P00005 · 2025 public law pricing updates $0
Exercise an Option P00004 · This modification is issued to exercise option year 2 on BPA 36E79723A0008. Period of performance is december 20, 2024 - december 19, 2025. $0
Supplemental Agreement for work within scope P00003 · 2024 public law pricing updates $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 on BPA 36E79723A0008. The period of performance is december 20, 2023 - december 19, 2024. $0
Supplemental Agreement for work within scope P00001 · 2023 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79723A0008?

36E79723A0008 was awarded to Radius Health, Inc. by National Acquisition Center (Headquarters) on December 20, 2022.

How much is contract 36E79723A0008 worth?

36E79723A0008's own ceiling is $18,500,000.

Who can order from contract 36E79723A0008?

36E79723A0008 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79723A0008 under another contract?

Yes. 36E79723A0008 is a blanket purchase agreement under 36F79718D0363, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79723A0008 competed?

The extent of competition for 36E79723A0008 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV